Recently, it was shown that inhibition of SphK2 by ABC294640 results in decreased c-Myc expression in acute lymphoblastic leukemia [25], multiple myeloma [26] and prostate cancer [29, 30] cells. Here, SPHK2 is linked to prostate cancer.